These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 16417267

  • 1. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
    Baker DP, Lin EY, Lin K, Pellegrini M, Petter RC, Chen LL, Arduini RM, Brickelmaier M, Wen D, Hess DM, Chen L, Grant D, Whitty A, Gill A, Lindner DJ, Pepinsky RB.
    Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters.
    Arduini RM, Li Z, Rapoza A, Gronke R, Hess DM, Wen D, Miatkowski K, Coots C, Kaffashan A, Viseux N, Delaney J, Domon B, Young CN, Boynton R, Chen LL, Chen L, Betzenhauser M, Miller S, Gill A, Pepinsky RB, Hochman PS, Baker DP.
    Protein Expr Purif; 2004 Apr; 34(2):229-42. PubMed ID: 15003256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS, Zhou J, Tang ZY, Fan J, Wu ZQ, Liu YK, Ye SL, Shen ZZ, Xue Q, Zhao Y.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3205-9. PubMed ID: 16405841
    [Abstract] [Full Text] [Related]

  • 8. PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis.
    Bansal R, Post E, Proost JH, de Jager-Krikken A, Poelstra K, Prakash J.
    J Control Release; 2011 Sep 25; 154(3):233-40. PubMed ID: 21664391
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43).
    Han JM, Myung H, Kim S.
    Cancer Lett; 2010 Jan 28; 287(2):157-64. PubMed ID: 19573982
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
    Pepinsky RB, Lee WC, Cornebise M, Gill A, Wortham K, Chen LL, Leone DR, Giza K, Dolinski BM, Perper S, Nickerson-Nutter C, Lepage D, Chakraborty A, Whalley ET, Petter RC, Adams SP, Lobb RR, Scott DM.
    J Pharmacol Exp Ther; 2005 Feb 28; 312(2):742-50. PubMed ID: 15485895
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
    Hamner JB, Sims TL, Cutshaw A, Dickson PV, Rosati S, McGee M, Ng CY, Davidoff AM.
    J Pediatr Surg; 2008 Jan 28; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
    Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW, Park SY, Kim YJ, Groves MD, Park K, Kim JH, Nam DH.
    Int J Oncol; 2006 Jun 28; 28(6):1385-92. PubMed ID: 16685440
    [Abstract] [Full Text] [Related]

  • 16. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A, Das RG.
    J Immunol Methods; 2005 Nov 30; 306(1-2):1-15. PubMed ID: 16226271
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a.
    Hu X, Olivier K, Polack E, Crossman M, Zokowski K, Gronke RS, Parker S, Li Z, Nestorov I, Baker DP, Clarke J, Subramanyam M.
    J Pharmacol Exp Ther; 2011 Sep 30; 338(3):984-96. PubMed ID: 21690216
    [Abstract] [Full Text] [Related]

  • 19. Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice.
    Takane H, Ohdo S, Yamada T, Yukawa E, Higuchi S.
    J Pharmacol Exp Ther; 2000 Aug 30; 294(2):746-52. PubMed ID: 10900256
    [Abstract] [Full Text] [Related]

  • 20. Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.
    Liu P, Zhang C, Chen J, Zhang R, Ren J, Huang Y, Zhu F, Li Z, Wu G.
    J Immunother; 2011 Apr 30; 34(3):320-6. PubMed ID: 21389866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.